ES8304200A1 - "un procedimiento para formar dna doble filamentado". - Google Patents

"un procedimiento para formar dna doble filamentado".

Info

Publication number
ES8304200A1
ES8304200A1 ES512354A ES512354A ES8304200A1 ES 8304200 A1 ES8304200 A1 ES 8304200A1 ES 512354 A ES512354 A ES 512354A ES 512354 A ES512354 A ES 512354A ES 8304200 A1 ES8304200 A1 ES 8304200A1
Authority
ES
Spain
Prior art keywords
human leukocyte
interferons
hybrid human
compositions containing
microbial production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512354A
Other languages
English (en)
Other versions
ES512354A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES8304200A1 publication Critical patent/ES8304200A1/es
Publication of ES512354A0 publication Critical patent/ES512354A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DNA DOBLE FILAMENTADO, QUE CODIFICA UN INTERFERON LEUCOCITARIO HUMANO HIBRIDO DE APROXIMADAMENTE 165-166 AMINOACIDOS. CONSISTE EN SELECCIONAR UN PRIMER FRAGMENTO DE DNA DOBLE FILAMENTADO QUE CONTIENE CODONES PARA LA PORCION AMINOTERMINAL DE UN INTERFERON LEUCOCITARIO Y UN SITIO DE DISOSIACION DE ENDONUCLEASA DE RESTRICCION; DISOCIAR EL FRAGMENTO CON LA ENDONUCLEASA; SELECCIONAR UN SEGUNDO FRAGMENTO DE DNA DOBLE FILAMENTADO, QUE CONTIENE CODONES PARA LA PORCION TERMINAL CARBOXILICA DE UN SEGUNDO INTERFERON; DISOCIAR EL SEGUNDO FRAGMENTO; Y LIGAR LOS PRODUCTOS DE DIGESTION DE ENDONUCLEASA. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE ENFERMEDADES NEOPLASTICAS VIRALES.
ES512354A 1980-11-10 1982-05-19 "un procedimiento para formar dna doble filamentado". Granted ES512354A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons

Publications (2)

Publication Number Publication Date
ES8304200A1 true ES8304200A1 (es) 1983-03-01
ES512354A0 ES512354A0 (es) 1983-03-01

Family

ID=27394813

Family Applications (2)

Application Number Title Priority Date Filing Date
ES506955A Expired ES8302778A1 (es) 1980-11-10 1981-11-07 Un procedimiento para producir un polipeptido antiviral.
ES512354A Granted ES512354A0 (es) 1980-11-10 1982-05-19 "un procedimiento para formar dna doble filamentado".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES506955A Expired ES8302778A1 (es) 1980-11-10 1981-11-07 Un procedimiento para producir un polipeptido antiviral.

Country Status (34)

Country Link
EP (1) EP0051873B1 (es)
JP (1) JP2642291B2 (es)
KR (1) KR920007439B1 (es)
AT (1) ATE46718T1 (es)
AU (1) AU555293B2 (es)
BR (1) BR8107293A (es)
CA (2) CA1212915A (es)
CH (2) CH663032A5 (es)
DE (2) DE3177106D1 (es)
DK (1) DK173590B1 (es)
DO (1) DOP1981004064A (es)
DZ (1) DZ350A1 (es)
ES (2) ES8302778A1 (es)
FI (1) FI79550C (es)
FR (1) FR2493867B1 (es)
GB (1) GB2090258B (es)
GR (1) GR81947B (es)
HK (1) HK51685A (es)
IE (1) IE51850B1 (es)
IL (1) IL64243A (es)
IT (1) IT1169276B (es)
KE (1) KE3536A (es)
LU (1) LU83745A1 (es)
MC (1) MC1424A1 (es)
MY (2) MY8700710A (es)
NL (1) NL189092C (es)
NO (1) NO165201C (es)
NZ (1) NZ198906A (es)
PH (1) PH18565A (es)
PL (1) PL233748A1 (es)
PT (1) PT73955B (es)
SE (1) SE460539B (es)
YU (1) YU46597B (es)
ZW (1) ZW26981A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657141A5 (de) * 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
WO1983000693A1 (en) * 1981-08-14 1983-03-03 Berg, Kurt, Frimann SUBJECTS RELATING TO HUMAN INTEFERON-'alpha' SUBTYPE PROTEINS AND CORRESPONDING ANTIBODIES
EP0072541A3 (en) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
WO1983002461A1 (en) * 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
GB2150573B (en) * 1983-02-24 1987-11-11 Inst Organicheskogo Sinteza Ak Leukocytic human interferon n and method to obtain it in bacterial cells
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (en) * 1984-08-31 1986-03-12 University Patents, Inc. Hybrid lymphoblastoid-leukocyte human interferons
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4885166A (en) * 1985-06-11 1989-12-05 Ciba-Geigy Corporation Hybrid interferons
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst LUNG SURFACE ACTIVE PROTEINS.
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
US6251939B1 (en) 1995-06-07 2001-06-26 Promega Biosciences, Inc. Carbamate-based cationic lipids
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CA2566247A1 (en) 2004-05-19 2005-12-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
MX2007014524A (es) 2005-05-18 2008-02-07 Maxygen Inc Polipeptidos desarrollados de interferon-alfa.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8308534A1 (es) * 1980-01-08 1983-09-01 Biogen Nv Un metodo de producir un polipeptido que exhibe actividad inmunologica o biologica del interferon de leucocitos humanos.

Also Published As

Publication number Publication date
IL64243A (en) 1985-11-29
LU83745A1 (de) 1983-09-01
AU7730481A (en) 1982-05-20
EP0051873B1 (en) 1989-09-27
DE3144469A1 (de) 1982-09-02
FR2493867A1 (fr) 1982-05-14
ES506955A0 (es) 1983-02-01
EP0051873A2 (en) 1982-05-19
IE812622L (en) 1982-05-10
ES8302778A1 (es) 1983-02-01
FI79550B (fi) 1989-09-29
NL189092C (nl) 1993-01-04
DK173590B1 (da) 2001-04-02
CA1212915A (en) 1986-10-21
GB2090258B (en) 1984-05-02
EP0051873A3 (en) 1982-09-22
DOP1981004064A (es) 1988-03-16
AU555293B2 (en) 1986-09-18
SE460539B (sv) 1989-10-23
CA1277616C (en) 1990-12-11
CH663032A5 (de) 1987-11-13
MC1424A1 (fr) 1982-10-18
KR920007439B1 (ko) 1992-09-01
MY8800066A (en) 1988-12-31
NL8105078A (nl) 1982-06-01
DZ350A1 (fr) 2004-09-13
NO165201C (no) 1991-01-16
GB2090258A (en) 1982-07-07
NZ198906A (en) 1985-12-13
YU46597B (sh) 1994-01-20
GR81947B (es) 1984-12-12
IE51850B1 (en) 1987-04-15
NO165201B (no) 1990-10-01
DK494681A (da) 1982-05-11
PT73955A (en) 1981-12-01
ATE46718T1 (de) 1989-10-15
FI813539L (fi) 1982-05-11
MY8700710A (en) 1987-12-31
KE3536A (en) 1985-06-07
IL64243A0 (en) 1982-02-28
DE3177106D1 (en) 1989-11-02
ES512354A0 (es) 1983-03-01
NO813785L (no) 1982-05-11
HK51685A (en) 1985-07-12
BR8107293A (pt) 1982-08-03
FI79550C (fi) 1990-01-10
PT73955B (en) 1983-11-23
ZW26981A1 (en) 1982-06-02
FR2493867B1 (fr) 1986-06-27
SE8106641L (sv) 1982-06-24
KR830007825A (ko) 1983-11-07
IT1169276B (it) 1987-05-27
JP2642291B2 (ja) 1997-08-20
JPH07308191A (ja) 1995-11-28
PL233748A1 (en) 1983-07-18
PH18565A (en) 1985-08-09
IT8124967A0 (it) 1981-11-10
NL189092B (nl) 1992-08-03
YU265681A (en) 1984-08-31
CH660743A5 (de) 1987-06-15

Similar Documents

Publication Publication Date Title
ES8302778A1 (es) Un procedimiento para producir un polipeptido antiviral.
ES8207514A1 (es) Un procedimiento para la preparacion de interferon
ES8306324A1 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
SG38692G (en) Microbially prepared interferon alpha 2(arg),dna sequence coding for said interferon,microorganisms containing this genetic information and process for their production
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
IE822479L (en) Dna molecules encoding certain mammalian proteins
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
ATE43139T1 (de) Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon.